{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:01:21Z","timestamp":1767866481047,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["T32HL007675"],"award-info":[{"award-number":["T32HL007675"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["R01 HL76246"],"award-info":[{"award-number":["R01 HL76246"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["R01 HL85440"],"award-info":[{"award-number":["R01 HL85440"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL007675"],"award-info":[{"award-number":["T32HL007675"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL76246"],"award-info":[{"award-number":["R01 HL76246"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL85440"],"award-info":[{"award-number":["R01 HL85440"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ajpath.2015.12.017","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T14:12:56Z","timestamp":1457187176000},"page":"1114-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis"],"prefix":"10.1016","volume":"186","author":[{"given":"Olga","family":"Frunza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti V.","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Humeres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqas","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikrant","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos G.","family":"Frangogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2015.12.017_bib1","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(17)41797-2","article-title":"Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages","volume":"269","author":"Sato","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.12.017_bib2","first-page":"1016","article-title":"Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages","volume":"147","author":"Liu","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s004410100457","article-title":"Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts. Comparison of cell type-specific expression profiles and subcellular localization","volume":"307","author":"Kaltner","year":"2002","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ard.2004.023135","article-title":"Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein","volume":"64","author":"Neidhart","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpath.2015.12.017_bib5","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.4049\/jimmunol.179.11.7800","article-title":"Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow","volume":"179","author":"Rao","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF00731282","article-title":"Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion","volume":"11","author":"Lotan","year":"1994","journal-title":"Glycoconj J"},{"key":"10.1016\/j.ajpath.2015.12.017_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajpath.2015.12.017_bib8","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3","volume":"180","author":"MacKinnon","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib9","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.4049\/jimmunol.1201851","article-title":"Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication","volume":"189","author":"Dragomir","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib10","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.4049\/jimmunol.181.4.2781","article-title":"Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib11","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.12.017_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/excr.1998.4253","article-title":"Galectin-3 stimulates cell proliferation","volume":"245","author":"Inohara","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajpath.2012.09.022","article-title":"Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction","volume":"182","author":"Seropian","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"de Boer","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpath.2015.12.017_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study","volume":"5","author":"Felker","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpath.2015.12.017_bib19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","article-title":"Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure","volume":"102","author":"Lok","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib21","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2015.12.017_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpath.2015.12.017_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ajpath.2015.12.017_bib24","series-title":"National Research Council: Guide for the Care and Use of Laboratory Animals: Eighth Edition","year":"2011"},{"key":"10.1016\/j.ajpath.2015.12.017_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00418-008-0541-5","article-title":"Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload","volume":"131","author":"Xia","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/HYPERTENSIONAHA.111.175323","article-title":"Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism","volume":"58","author":"Xia","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2015.12.017_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1369\/0022155413493912","article-title":"Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction","volume":"61","author":"Christia","year":"2013","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ajpath.2015.12.017_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ajpath.2015.12.017_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cvr\/cvu138","article-title":"CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans","volume":"103","author":"Saxena","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib30","doi-asserted-by":"crossref","first-page":"H1233","DOI":"10.1152\/ajpheart.00328.2014","article-title":"Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function","volume":"307","author":"Saxena","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib31","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/CIRCRESAHA.113.302593","article-title":"Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation","volume":"113","author":"Gonzalez-Quesada","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib32","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.1300725","article-title":"IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium","volume":"191","author":"Saxena","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.109.216101","article-title":"Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction","volume":"107","author":"Dobaczewski","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/CIRCHEARTFAILURE.114.001963","article-title":"Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice","volume":"8","author":"Biernacka","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpath.2015.12.017_bib35","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-beta signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00005-009-0024-y","article-title":"The role of IL-1 in the pathogenesis of heart disease","volume":"57","author":"Bujak","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.ajpath.2015.12.017_bib37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.170.6.1959","article-title":"The Mac-2 antigen is a galactose-specific lectin that binds IgE","volume":"170","author":"Cherayil","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2015.12.017_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cvr\/cvr080","article-title":"Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm","volume":"91","author":"Kaneko","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/CIRCRESAHA.109.199471","article-title":"Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction","volume":"105","author":"Bujak","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib40","doi-asserted-by":"crossref","first-page":"13531","DOI":"10.1073\/pnas.1735526100","article-title":"Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading","volume":"100","author":"Rong","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.12.017_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/01.HYP.25.1.98","article-title":"Myocardial remodeling in hypertensive Ren-2 transgenic rats","volume":"25","author":"Villarreal","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2015.12.017_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1083\/jcb.133.1.159","article-title":"Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells","volume":"133","author":"Saada","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib43","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.4049\/jimmunol.149.12.4002","article-title":"Role of colony-stimulating factor-1 in macrophage activation in tumor-bearing mice","volume":"149","author":"Sakata","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2015.12.017_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/excr.1995.1331","article-title":"Intranuclear distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron microscopy","volume":"220","author":"Hubert","year":"1995","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/excr.1999.4782","article-title":"Galectin-3 expression and subcellular localization in senescent human fibroblasts","volume":"255","author":"Openo","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib47","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1073\/pnas.93.13.6737","article-title":"Expression of galectin-3 modulates T-cell growth and apoptosis","volume":"93","author":"Yang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.12.017_bib48","first-page":"5272","article-title":"Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family","volume":"57","author":"Akahani","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.12.017_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2015.12.017_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0002-9440(10)64975-9","article-title":"Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses","volume":"156","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.12.017_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2015.12.017_bib52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Martinez-Martinez","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2015.12.017_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10557-014-6520-2","article-title":"Galectin-3: a modifiable risk factor in heart failure","volume":"28","author":"de Boer","year":"2014","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401600078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401600078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T20:15:36Z","timestamp":1718396136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401600078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S000294401600078X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.12.017","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}